Limited coverage drugs – ciprofloxacin ophthalmic
Last updated on October 7, 2022
| Generic name |
ciprofloxacin ophthalmic |
|---|---|
| Strength | 0.3 % |
| Form | eye drop |
|
Special Authority criteria |
Approval period |
|---|---|
|
Failure or intolerance to first-line agents. (e.g., aminoglycosides) |
Short term |
Practitioner exemptions
- Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
- Ophthalmologists
Special notes
- None